Business / Finance

RSS

Henry Schein's net sales increase 2.4% to $2.7 billion in third quarter 2015

Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, today reported record third quarter financial results.

4 Nov 2015

U.S. FTC clears Mylan's proposed transaction to acquire Perrigo

Mylan N.V. today announced the U.S. Federal Trade Commission has cleared the company's proposed transaction to acquire Perrigo Company plc subject to Mylan's divestiture of certain products following the consummation of the offer.

4 Nov 2015

OncoSec signs definitive agreements to purchase $7.5 million of securities in registered direct offering

OncoSec Medical Incorporated, a company developing DNA-based intratumoral cancer immunotherapies, announced today that it has entered into definitive agreements with institutional investors to purchase approximately $7.5 million of securities in a registered direct offering.

4 Nov 2015

‘Zero pressure’ mattress solutions to be showcased at MEDICA 2015

‘Stop the Pressure’ is the message from pressure ulcer specialist Rober, who is showcasing their wide range of innovative mattresses in support of Worldwide STOP Pressure Ulcer Day at MEDICA 2015, the world’s largest healthcare technology exhibition.

4 Nov 2015

Surgical startup seeks funding to build virtual reality training library

Medical Realities, a pioneering medical training startup, today announced that it is raising £400,000 in new investment to improve surgical education by creating a series of virtual and augmented reality training tutorials.

4 Nov 2015

Medigus announces CMS’ publication of fee schedules for endoscopic fundoplication procedures under CPT code 43210 effective January 2016

Medigus Ltd., a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, today announced that following the American Medical Association’s (AMA) decision earlier this year to create a new Category I Current Procedural Terminology (CPT®) code for esophagogastric fundoplast...

3 Nov 2015

Denator forms a new Scientific Advisory Board

Denator AB has announced that a new external expert advisory board has been formed. Karsten Fjärstedt, recently appointed as CEO comments, “It is a great honor for me to be entrusted to lead Denator forward in this new phase of development. With a pipeline of new exciting business opportunities and a strong Scientific Advisory Board (SAB) I am looking forward to realizing the full potential of the company technology”.

3 Nov 2015

Alnylam presents positive ongoing phase 2 open-label extension data for Patisiran and Revusiran

Alnylam Pharmaceuticals, Inc. has announced new results from its ongoing Phase 2 open-label extension (OLE) studies with patisiran and revusiran, investigational RNAi therapeutics targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR amyloidosis).

3 Nov 2015

Digital health startup boot camp expands to US

Startupbootcamp, a global family of industry - focused accelerators, has today announced the launch of its first accelerator programs in North America, Startupbootcamp Digital Health.

3 Nov 2015

CureVac raises €100M to enable rapid expansion of mRNA development platform, clinical-stage pipeline

CureVac, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based technology, today announces that it has raised about $110 million (€100 million) to enable accelerated expansion of its industry-leading messenger RNA (mRNA) development platform and clinical-stage pipeline.

3 Nov 2015

Addus HomeCare’s net service revenues increase 3.3% to $84.3 million in Q3 2015

Addus HomeCare Corporation, a comprehensive provider of home and community-based services that are primarily personal in nature, provided in the home and focused on the dual eligible population, today announced its financial results for the third quarter and nine months ended September 30, 2015.

3 Nov 2015

HealthSouth acquires home health and hospice agency operations of CareSouth Health System

HealthSouth Corporation, a leading provider of post-acute healthcare services, today announced its Encompass Home Health business unit has completed its previously announced acquisition of the home health and hospice agency operations of CareSouth Health System, Inc.

2 Nov 2015

Xcelience announces grand opening of new headquarters in Tampa

Xcelience is proud to announce the grand opening of its new 71,000 square foot headquarters located at 4910 Savarese Circle in Tampa. The building houses preformulation and formulation development labs and suites, as well as analytical and stability services. The official ribbon cutting ceremony was attended by Florida Governor Rick Scott, Tampa Mayor Bob Buckhorn and other elected and non-elected officials.

31 Oct 2015

Alexza plans to reacquire U.S. rights for ADASUVE (loxapine) inhalation powder from Teva

Alexza Pharmaceuticals, Inc. announced today that it plans to reacquire the U.S. rights for ADASUVE (loxapine) inhalation powder from Teva Pharmaceuticals USA, Inc., a subsidiary of Teva Pharmaceutical Industries Ltd., with an estimated target completion date of January 1, 2016.

31 Oct 2015

Q BioMed signs definitive license agreement with Mannin Research

Q BioMed Inc., a biotechnology acceleration company is pleased to announce it has signed a definitive license, with the option to acquire, the platform technology assets of Mannin Research Inc.

30 Oct 2015

Semler Scientific's revenue up 74% in third quarter 2015

Semler Scientific, Inc., a company that provides diagnostic and testing services to healthcare insurers and physician groups, today reported financial results for the third quarter ended September 30, 2015.

30 Oct 2015

Omnicell's revenue increases 11.0% to $125.2 million in Q3 2015

Omnicell, Inc., a leading provider of medication and supply management solutions to healthcare systems, today announced results for its third quarter ended September 30, 2015.

From Omnicell, Inc. 30 Oct 2015

Omnicell signs definitive agreement to acquire Aesynt

Omnicell, Inc., a leading provider of medication and supply management solutions to healthcare systems, today announced it has entered into a definitive agreement to acquire Aesynt Incorporated.

From Omnicell, Inc. 30 Oct 2015

Tandem Diabetes Care sales grow 16% to $15.7 million in third quarter 2015

Tandem Diabetes Care, Inc., a medical device company and manufacturer of the t:slim, t:flex and t:slim G4 Insulin Pumps, today reported its financial results for the quarter ended September 30, 2015.

30 Oct 2015

Ultragenyx, Arcturus sign agreement to develop mRNA therapeutics to certain rare diseases

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, and Arcturus Therapeutics, Inc., a leading RNA medicines company, today announced that they have entered into a research collaboration and license agreement to discover and develop messenger RNA (mRNA) therapeutics to certain rare disease targets using Arcturus' UNA Oligomer chemistry and LUNAR nanoparticle delivery platform.

29 Oct 2015